Lumos Pharma Announces Participation in Investor

AUSTIN, Texas, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company advancing an oral therapeutic candidate...

Related Keywords

Texas ,United States ,New York ,Lumos Pharma ,Lisa Miller ,Lumos Pharma Inc ,Nasdaq ,Pediatric Growth Hormone Deficiency ,Annual Global Investment Conference ,Cantor Global Healthcare Conference ,Pharma Corporate Presentation ,Global Healthcare Conference ,Lumos Pharma Investor Relations ,Orphan Drug Designation ,Media Contact ,Nasdaq Lumo ,Nc ,Biotechnology ,Health ,Medical ,Cghd ,Pharmaceuticals ,